Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 44.12%8.71B | ---- | ---- | ---- | 38.23%6.05B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | -13.69%-1.2B | ---- | ---- | ---- | -47.96%-1.05B | ---- | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | 0.00%124M | ---- | ---- | ---- | 7.83%124M | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | -13.33%-17M | ---- | ---- | ---- | -7.14%-15M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 24.41%-96M | ---- | ---- | ---- | -234.21%-127M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | 102.50%81M | ---- | ---- | ---- | -14.89%40M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 102.50%81M | ---- | ---- | ---- | -14.89%40M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | 416.67%38M | ---- | ---- | ---- | 72.09%-12M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | 416.67%38M | ---- | ---- | ---- | 72.09%-12M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | -2.59%978M | ---- | ---- | ---- | -13.45%1B | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | -2.59%978M | ---- | ---- | ---- | -13.45%1B | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | -276.47%-30M | ---- | ---- | ---- | 342.86%17M | ---- | ---- |
| Special items | ---- | ---- | ---- | -12.09%567M | ---- | ---- | ---- | 23.09%645M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 37.37%9.16B | ---- | ---- | ---- | 23.36%6.67B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -314.29%-15M | ---- | ---- | ---- | -30.00%7M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -164.22%-539M | ---- | ---- | ---- | -122.52%-204M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 3,448.08%1.85B | ---- | ---- | ---- | -92.16%52M | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | -71.54%265M | ---- | ---- | ---- | 45.02%931M | ---- | ---- |
| Cash from business operations | ---- | ---- | ---- | 43.76%10.72B | ---- | ---- | ---- | -2.26%7.46B | ---- | ---- |
| Other taxs | ---- | ---- | ---- | -64.24%-1.36B | ---- | ---- | ---- | -12.55%-825M | ---- | ---- |
| Interest received - operating | ---- | ---- | ---- | 29.14%913M | ---- | ---- | ---- | 20.44%707M | ---- | ---- |
| Special items of business | 0.58%7.84B | -26.16%4.16B | -6.22%2.52B | ---- | 45.43%7.8B | 43.66%5.63B | 45.03%2.69B | ---- | 7.48%5.36B | 4.93%3.92B |
| Net cash from operations | 0.58%7.84B | -26.16%4.16B | -6.22%2.52B | 40.04%10.28B | 45.43%7.8B | 43.66%5.63B | 45.03%2.69B | -1.92%7.34B | 7.48%5.36B | 4.93%3.92B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | -51.59%61M | ---- | ---- | ---- | 70.27%126M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | 137.50%9M | ---- | ---- | ---- | ---24M | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | -571.50%-5.61B | ---- | ---- | ---- | -11.48%-835M | ---- | ---- |
| Purchase of fixed assets | ---- | ---- | ---- | -93.33%-319M | ---- | ---- | ---- | -94.12%-165M | ---- | ---- |
| Purchase of intangible assets | ---- | ---- | ---- | 28.63%-713M | ---- | ---- | ---- | -3.20%-999M | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | 20,328.81%12.05B | ---- | ---- | ---- | -95.14%59M | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | -48,924.00%-12.26B | ---- | ---- | ---- | 96.85%-25M | ---- | ---- |
| Other items in the investment business | 37.39%-5.1B | 19.79%-3.85B | 41.42%-3.22B | ---21M | -387.54%-8.14B | -810.04%-4.81B | -777.93%-5.5B | ---- | -394.08%-1.67B | -158.34%-528M |
| Net cash from investment operations | 37.39%-5.1B | 19.79%-3.85B | 41.42%-3.22B | -265.97%-6.82B | -387.54%-8.14B | -810.04%-4.81B | -777.93%-5.5B | -28.84%-1.86B | -394.08%-1.67B | -158.34%-528M |
| Net cash before financing | 890.20%2.74B | -63.27%303M | 75.04%-702M | -36.85%3.46B | -109.40%-347M | -75.67%825M | -205.60%-2.81B | -9.30%5.47B | -20.63%3.69B | -26.92%3.39B |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | ---- | ---- | -1.71%-119M | ---- | ---- | ---- | -1.74%-117M | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | -3,652.38%-1.58B | ---- | ---- | ---- | 40.00%-42M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | --6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -54.12%-1.93B | ---- | ---- | ---- | 60.06%-1.25B | ---- | ---- |
| Other items of the financing business | -53.70%-4.63B | -17.77%-2.51B | 12.64%-456M | -485.71%-82M | -213.41%-3.02B | -1,787.61%-2.13B | -552.50%-522M | -160.87%-14M | 68.31%-962M | 91.74%-113M |
| Net cash from financing operations | -53.70%-4.63B | -17.77%-2.51B | 12.64%-456M | -149.02%-3.83B | -213.41%-3.02B | -1,787.61%-2.13B | -552.50%-522M | 55.02%-1.54B | 68.31%-962M | 91.74%-113M |
| Effect of rate | -525.00%-17M | 650.00%44M | 206.67%16M | -139.47%-30M | -95.92%4M | -106.84%-8M | -66.67%-15M | -78.16%76M | -74.07%98M | -35.36%117M |
| Net Cash | 43.72%-1.89B | -68.88%-2.21B | 65.27%-1.16B | -109.48%-373M | -223.24%-3.36B | -139.90%-1.31B | -229.07%-3.33B | 50.46%3.94B | 69.13%2.73B | 0.18%3.28B |
| Begining period cash | -2.97%13.16B | -2.97%13.16B | -2.97%13.16B | 41.99%13.57B | 41.99%13.57B | 41.99%13.57B | 41.99%13.57B | 44.97%9.56B | 44.97%9.56B | 44.97%9.56B |
| Cash at the end | 10.25%11.26B | -10.22%11B | 17.66%12.02B | -2.97%13.16B | -17.54%10.21B | -5.40%12.25B | -15.76%10.22B | 41.99%13.57B | 44.27%12.38B | 28.93%12.95B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.